AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

EQUALS GROUP PLC

Capital/Financing Update May 20, 2024

7629_rns_2024-05-20_dffc9fbb-f9be-4879-9016-82ea91f8d223.pdf

Capital/Financing Update

Open in Viewer

Opens in native device viewer

Company Announcement: JUE 13

JUEL GROUP P.L.C.

The following is a Company Announcement being made by Juel Group P.L.C. (the "Company") pursuant the Capital Markets Rules issued by the Malta Financial Services Authority.

QUOTE

PUBLICATION OF FINAL TERMS RELATIVE TO THE SERIES 2/2024, TRANCHE I NOTES

Reference is made to company announcement JUE 07 dated 9 April 2024 in which the Company announced that a base prospectus dated 8 April 2024 ("Base Prospectus"), relating to the issue of up to €5,000,000 unlisted unsecured notes ("Notes") pursuant to a note issuance programme (the "Note Issuance Programme"), has been approved by the Malta Financial Services Authority, as the competent authority under the Prospectus Regulation (Regulation EU No. 2017/1129).

In April 2024, the Company issued €3,500,000 6.5% notes 2027 – 2029 as part of Series 1/2024, Tranche I of the Note Issuance Programme, pursuant to the final terms relative to the first tranche of Notes dated 8 April 2024.

The Company hereby announces that it has published final terms dated 17 May 2024 relating to the issue by the Company of up to €1,500,000 6.5% unsecured notes 2027 – 2029 (the "Final Terms"). The new Notes to be offered by the Company are to be designated as Series 2/2024, Tranche I Notes.

The Final Terms must be read in conjunction with the Base Prospectus. The Base Prospectus and the Final Terms may be accessed and downloaded from the Company's website at: https://juel.mt/investor-relations/borrowings-from-the-financial-market/issue-of-global-notes/

UNQUOTE

BY ORDER OF THE BOARD

________________

Dr. Karen Coppini Company Secretary

20 May 2024

Talk to a Data Expert

Have a question? We'll get back to you promptly.